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Cells allocate substantial resources toward moni-
toring levels of nutrients that can be used for ATPgen-
eration bymitochondria. Among themany specialized
cell types, neurons are particularly dependent on
mitochondria due to their complex morphology and
regional energy needs. Here, we report a molecular
mechanism by which nutrient availability in the form
of extracellular glucose and the enzyme O-GlcNAc
Transferase (OGT), whose activity depends on
glucose availability, regulates mitochondrial motility
in neurons. Activation of OGT diminishes mitochon-
drial motility. We establish the mitochondrial motor-
adaptor protein Milton as a required substrate for
OGT to arrest mitochondrial motility by mapping and
mutating the key O-GlcNAcylated serine residues.
We find that the GlcNAcylation state of Milton is
altered by extracellular glucose and that OGT alters
mitochondrial motility in vivo. Our findings suggest
that, by dynamically regulating Milton GlcNAcylation,
OGT tailorsmitochondrial dynamics in neurons based
on nutrient availability.INTRODUCTION
Mitochondria form a dynamic, interconnected network and play
a vital role in cellular energetics by generating ATP, buffering cal-
cium, and participating in metabolic pathways. Positioning mito-
chondria in areas of high-energy consumption followed by the
induction of oxidative phosphorylation can allow cells to respond
to increased energy demands. Therefore, the molecular mecha-
nisms that relay signals to mitochondria about changes in local
nutrient status andmetabolic demand are critical for cell function
(Liesa and Shirihai, 2013; Nunnari and Suomalainen, 2012).54 Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc.Glucose is the predominant carbon source for ATP production
bymitochondria. Neuronal metabolism in particular relies heavily
on a continuous supply of glucose (Peppiatt and Attwell, 2004).
Moreover, due to their elaborate morphology and regional differ-
ences in energy use and nutrient access, glucose uptake and
handling are spatially heterogeneous in neurons (Ferreira et al.,
2011; Hall et al., 2012; Weisova´ et al., 2009). Mitochondrial dy-
namicsmay therefore need to respond to changes in the glucose
supply to ensure rapid ATP production, especially during intense
synaptic activity and action potential firing.
The distribution of neuronal mitochondria is determined by the
elaborate regulation of their motility (Chang et al., 2006). They
can move in either direction, pause, change direction, or remain
stationary. This behavior is primarily mediated by the interplay of
(+)-end directed kinesin, ()-end directed dynein motors, and
anchoring proteins (Schwarz, 2013).
The mitochondrial motor/adaptor complex plays a central
role in regulating this process (Wang and Schwarz, 2009b). The
mitochondrial receptor for this complex, the GTPase Miro (also
called RhoT1/2), interacts with the adaptor protein Milton (also
called TRAK1/2 and OIP106/98), which couples kinesin heavy
chain (KHC) and dynein/dynactin to mitochondria (Glater et al.,
2006; Macaskill et al., 2009; van Spronsen et al., 2013). Milton
also binds an enzyme called O-GlcNAc transferase (OGT) (Iyer
et al., 2003; Iyer and Hart, 2003). OGT catalyzes the addition of a
single sugar moiety onto serine and threonine residues of nuclear
and cytoplasmic proteins, including Milton, in a process called O-
GlcNAcylation. OGT has been considered a metabolic sensor for
glucose (Hartetal., 2011)becauseO-GlcNAcylation levelsare influ-
enced by glucose flux via the hexosamine biosynthetic pathway
(HBP), which produces the donor substrate, UDP-GlcNAc.
Although the OGT/Milton interaction is conserved from
Drosophila (Glater et al., 2006) to mammals (Brickley et al.,
2011; Iyer and Hart, 2003), its functional significance is unknown.
We hypothesized thatmitochondrial motility would be sensitive to
glucose levels and that OGT-dependent Milton O-GlcNAcylation
links glucose metabolism to the regulation of mitochondrial
motility.
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Figure 1. Increased Glucose Decreases Mitochondrial Motility in Rat Hippocampal Axons
(A) Schematic of the paradigm for changing extracellular glucose.
(B and C) The sensor FLII12Pglu-600md6 was expressed in cultured rat hippocampal neurons and the YFP/CFP ratio used to determine intracellular glucose
concentration in 5 mM and after switching to 30 mM glucose medium.
(B) Pseudocolored pixel-by-pixel ratio of a neuron before and after the switch to 30 mM glucose (scale bar, 10 mm).
(C) Normalized YFP/CFP ratios from neurons cultured in 5 mM glucose before and after exchange (arrow) of medium for either fresh 5mM glucose (solid circle) or
30 mM glucose (solid square). 30 mM extracellular glucose caused 2-fold increase in intracellular glucose (p = 0.0007, n > 4, three independent transfections).
(D and E) Representative kymographs of mitochondrial motility in hippocampal axons transfected with Mito-DsRed and synaptophysin (Syp)-CFP and imaged
after culturing as schematized in (A). Here and in subsequent figures, the first frame of each time-lapse movie is shown above a kymograph generated from that
region of axon. The y axis of each kymograph represents time, and the x axis depicts the position of the organelles such that stationary organelles appear as
vertical lines, whereas those moving either anterograde or retrograde are diagonal. Scale bars, 10 mm and 100 s.
(F andG) The percent time eachmitochondrion (F) or Syp vesicle (G) spent in anterograde and retrogrademotion was calculated from kymographs like those in (D)
and (E). n = 73–101 mitochondria from 8 axons, and n = 114–126 vesicles from 7 axons and 4 independent transfections per condition.
*p < 0.05 and **p < 0.01; Mann-Whitney U test. All values are shown as mean ± SEM. See also Movies S1, S2, S3, and S4 and Table S1.RESULTS
Increased Extracellular Glucose Decreases
Mitochondrial Motility in Hippocampal Axons
To examine the effects of elevated extracellular glucose on
axonal mitochondrial motility, we performed live-cell imaging in
rat hippocampal neurons expressing Mito-DsRed, a mitochon-drial marker, and synaptophysin-CFP (Syp-CFP), a marker of
synaptic vesicle precursors. Normal neurobasal (NB) medium
contains a high level of glucose (25 mM), which likely saturates
glucose transporters. Therefore, we switched established cul-
tures to a preconditioning 5mMglucosemedium for 70 hr before
challenging themwith elevated (30mM) glucose (Figure 1A). Live
imaging of a fluorescent glucose sensor (Hou et al., 2011)Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc. 55
CONTROL OGT OGTH498N PUGNAC
0
5
10
15
20
25
CONTROL OGT OGTH498N PUGNAC
0
5
10
15
20
25
Pe
rc
en
t T
im
e 
in
 M
ot
io
n
Pe
rc
en
t T
im
e 
in
 M
ot
io
n edargorteRedargoretnA
*
****
****
****
n.s.
n.s.
CONTROL OGT
0
5
10
15
20
25
CONTROL OGT
0
5
10
15
20
25
Pe
rc
en
t T
im
e 
in
 M
ot
io
n
Pe
rc
en
t T
im
e 
in
 M
ot
io
nAnterograde Retrograde
n.s.
n.s.
DC
A TGOLORTNOC
OGT
B
Mito-DsRed
edargoretnAedargorteR edargoretnAedargorteR
Mito-DsRed
)PFC-pyS( selcisev-pyS)deRsD-otiM( airdnohcotiM
Mito-DsRed
edargoretnAedargorteR
scrambled 
shRNA 
E OGT shRNA 
Mito-DsRed
F
0
5
10
15
20
25
***
0
5
10
15
20
25
****
scrambled scrambledOGT OGTshRNA:
G
Pe
rc
en
t T
im
e 
in
 M
ot
io
n Anterograde Retrograde
Glucose
Glucose-6-phosphate
Fructose-6-phosphate
GFAT DON
Glucosamine-6-phosphate
UDP-GlcNAc
PUGNACOGA
OGT
S/T S/T S/T S/T
Glc
NA
c
Glycolysis
Glc
NA
c
Glucosamine
H
0
5
10
15
20
0
5
10
15
20
Pe
rc
en
t T
im
e 
in
 M
ot
io
n
Pe
rc
en
t T
im
e 
in
 M
ot
io
n
Mito-DsRed
edargoretnAedargorteR 1mM glucose
Mito-DsRed
edargoretnAedargorteR 2h 5mM glucose
DON + 2h 5mM glucoseDON + 2h glucosamine
Mito-DsRed
Mito-DsRed
DON + + 
_ 
2h 5mM glucose _ + + _ _ 
2h glucosamine
_ _ 
_ _ _ + + 
+ + _ 
_ 
+ + 
_ _ 
_ _ 
_ _ _ + + 
Anterograde Retrograde
I J
K L
M
DON 
2h 5mM glucose
2h glucosamine
n.s.n.s.
****
***
***
****.
n.s.
n.s.
**
*
****.
n.s.
(legend on next page)
56 Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc.
confirmed that this extracellular shift altered intracellular glucose
concentration (Figures 1B and 1C). The transporter that likely
mediates this increase, GLUT3, was present at neuronal cell
bodies and densely spaced patches along processes (Figure S1
available online) (Choeiri et al., 2002; Ferreira et al., 2011); mito-
chondria throughout the cell are therefore likely to experience the
shift in intracellular glucose.
To compare their dynamics in neurons maintained in 5 mM
(Movies S1 and S2) or shifted to 30 mM glucose (Movies S3
and S4), we determined the percent time each mitochondrion
and Syp-vesicle spent in motion, their average velocity, and total
distance traveled, as well as mitochondrial length and density
(Table S1). Increasing extracellular glucose reduced both anter-
ograde and retrograde movement of mitochondria (Figures
1D–1F). Mitochondrial density also decreased in axons, poten-
tially due to decreased movement of mitochondria into the
axon from the cell body (Table S1A). The reduction was specific
to mitochondria; movement of Syp-vesicles in the same
axons increased significantly in both directions (Figure 1G and
Table S1A) even as mitochondrial movement decreased. The
enhancedmovement of Syp vesicles entailed increases in veloc-
ity and total distance traveled.
Increased O-GlcNAc Transferase Activity Arrests
Mitochondria
We hypothesized that OGT was responsible for the effect of
elevated glucose on mitochondrial movement. We therefore
examined the effect of OGT by transfecting neurons with the
full-length nucleocytoplasmic isoform of OGT together with
Mito-DsRed and Syp-CFP. OGT overexpression reduced axonal
mitochondrial motility and density (Figure 2, Table S1B, and
Movies S5 and S6). In contrast, OGT did not decrease the move-
ment of Syp-vesicles. Expression of OGTH498N, a mutant lacking
catalytic activity (Lazarus et al., 2011) (Figure S2A), did not signif-
icantly change mitochondrial motility (Figure 2C). To increase O-
GlcNAcylation without overexpressing OGT, we instead treated
neurons with O-(2-acetamido-2-deoxy-D-glucopyranosylidene)
amino-N-phenylcarbamate (PUGNAC), an inhibitor of the
de-GlcNAcylating enzyme OGA. PUGNAC also reduced mito-
chondrial motility (Figure 2C). Thus, either the expression of
catalytically active OGT or the inhibition of endogenous OGA
mimicked the effect of elevatedglucoseonmitochondrialmotility.Figure 2. OGT and the Hexosamine Pathway Inhibit Mitochondrial Mo
(A and B) Kymographs of axons from hippocampal neurons transfected with Mito-
the transfection.
(C and D) The percent of time mitochondria (C) and Syp vesicles (D) spent in m
transfected with either OGT or the catalytically inactive OGTH498N or neurons pret
and n = 118–165 vesicles from 7 to 8 axons and 4 independent transfections pe
(E–G) Hippocampal neuronswere transfected withMito-DsRed and either a scram
their consequences for mitochondrial motility were quantified (G). n = 175–179 m
(H) Schematic representation of glucose and glucosamine metabolism by the HB
(I–M) Hippocampal neurons, cultured in 5 mM glucose, were transfected with Mito
Figure 1A). Mitochondrial motility was imaged with the indicated glucose, gluco
glucose and 2 hr after shift to 5mMglucose. (K and L) Addition of theGFAT inhibito
but not by 2 hr exposure to 1 mM glucose and 4 mM glucosamine (K). (M) Mitoc
experiments in (I)–(M), medium was supplemented with 1 mM lactate and 1 mM p
transfections per condition.
n.s., not significant. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001; Kruskal
See also Figure S2, Movies S5 and S6, and Table S1B.We also probed the influence of OGT by pharmacologically
manipulating the availability of its substrate UDP-GlcNAc. UDP-
GlcNAc synthesis can be blocked with 6-diazo-5-oxo-L-norleu-
cine (DON), an inhibitor of glutamine fructose-6-phosphate
amidotransferase (GFAT). We therefore cultured hippocampal
neurons expressing OGT in 5 mM glucose for 72 hr either in the
presence or absence of 10 mM DON. DON alone did not alter
mitochondrial motility, but it prevented the inhibition of move-
ment caused by OGT overexpression (Figures S2B–S2F). These
observations were consistent with a model in which increased
glucose availability stimulated OGT activity (Butkinaree et al.,
2010; Love and Hanover, 2005) and thereby inhibited the move-
ment of mitochondria.
To assess whether reducing endogenous OGT alters mito-
chondrial motility, we depleted OGT from neurons by coexpress-
ing GFP with a short hairpin RNA (shRNA) against OGT (Caldwell
et al., 2010). The efficacy of the shRNAwas established in hippo-
campal neurons after 4 days of expression (Figure S2G) and in
HEK293T cells (Figure S2H). OGT depletion enhanced mito-
chondrial motility in both directions (Figures 2E–2G and Table
S1B). This enhancement was suppressed by expression of
shRNA-resistant OGT (Figures S2I and S2J) and was specific
to mitochondria because the retrograde trafficking of late endo-
somal vesicles (visualized by RFP-Rab7) was inhibited by OGT
depletion (Figure S2K).
Regulation of Mitochondrial Motility in the Physiological
Range of Glucose Concentrations
Although neurons are normally cultured in 25 mM glucose,
extracellular glucose ranges from 2 to 6 mM in mammalian
brain (Silver and Erecinska, 1994). To examine mitochondrial
motility at concentrations resembling those in vivo, we
cultured hippocampal neurons in 5 mM glucose containing
NB medium and then lowered the glucose to 1 mM for
48 hr before challenging them with 5 mM glucose for 2 hr.
1 mM lactate and pyruvate were present throughout as alter-
native energy supplies that are not metabolized to UDP-
GlcNAc. Shifting to higher extracellular glucose again reduced
mitochondrial movement (Figures 2I, 2J, and 2M). Consistent
with mediation by the HBP, the reduction was blocked by
DON (Figures 2H–2M). Glucosamine, which enters the HBP
downstream of GFAT, also reduced mitochondrial movement,tility
DsRed and Syp-CFP either with (A) or without (B) OGT and imaged 3 days after
otion was quantified from kymographs of either control cultures or neurons
reated for 6 hr with 100 mM PUGNAC. n = 100–129 mitochondria from 8 axons,
r condition.
bled shRNA (E) or OGT shRNA (F) and imaged 4 days after the transfection, and
itochondria from 9 axons and 3 independent transfections per condition.
P. Rate-limiting steps and the inhibitors used in this study are also indicated.
-DsRed and transferred to media containing 1 mM glucose for 48 hr (similar to
samine, and DON treatments. (I and J) Representative kymographs at 1 mM
r DON (100 mM) prevented the reduction inmotility caused by 5mMglucose (L),
hondrial motility was quantified from kymographs as in (I)–(L). Throughout the
yruvate; n = 116–199 mitochondria from 8 to 13 axons and 3 to 4 independent
-Wallis test. All values are shown as mean ± SEM. Scale bars, 10 mm and 100 s.
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and, as predicted, this reduction was not blocked by DON
(Figure 2M).
Milton Recruits OGT to Mitochondria and Undergoes
Regulated O-GlcNAcylation
To determine whether the interaction with Milton caused OGT to
be recruited to the mitochondrial surface, we transfected both
COS7 cells and neurons with Mito-DsRed and eGFP-tagged
OGT in the presence and absence of myc-hMilton1. Expression
of the tagged OGT allowed us to distinguish mitochondrial
binding of the nucleocytoplasmic isoform in the transgene from
an intramitochondrial variant that also occurs in cells (Love
and Hanover, 2005). In the absence of Milton expression,
eGFP-OGT was largely diffuse in the COS7 cytosol and nucleus,
although some was present on mitochondria. With Milton over-
expression (Figure S3A), eGFP-OGT was highly mitochondrial.
Similarly, in neuronal processes, eGFP-OGT became highly en-
riched on mitochondria when Milton was coexpressed (Figures
3A–3D). Miro or KHC coexpression did not enrich eGFP-OGT
on mitochondria (data not shown).
To test the possibility that OGT arrests mitochondrial motility
through dissociation of theMilton/KHC/Miro complex, we immu-
noprecipitated hMilton1 from HEK293T cells with or without
overexpression of OGT. Endogenous OGT coprecipitated with
hMilton1, but overexpression of OGT greatly enhanced this as-
sociation (Figure 3E). However, as OGT-hMilton1 association
increased, levels of coprecipitated kinesin and Miro remained
constant. Moreover, immunoprecipitation of an epitope-tagged
kinesin pulled down both endogenous and overexpressed
OGT, together with hMilton1 (Figure S3B). Thus, association of
OGT with Milton did not disrupt the mitochondrial motor/adaptor
complex (Figures 3E and S3B) and OGT bound to complexes
that also contain KHC.
We examined O-GlcNAcylation of myc-tagged hMilton1 to
determine whether the extent of its modification was altered
when OGT was overexpressed or OGA was inhibited. Anti-
GlcNAc antibodies detected a band that comigrated with
hMilton1 in anti-myc immunoprecipates from HEK293T cells
expressing myc-tagged hMilton1 (Figure 3F). Intensity of this
band was increased by inhibition of OGA by PUGNAC, overex-
pression of OGT, or both combined (Figures 3F and 3G),
but overexpression of OGTH498N did not (Figures 3H and 3I).
PUGNAC also increased the GlcNAcylation state of endogenous
hMilton1 (Figure S3C). Thus, GlcNAcylation sites on Milton are
not saturated in control conditions, and the level of their modifi-
cation is likely to be determined by the balance of OGT and OGA
activity.
A Stable OGT-Milton Interaction Is Not Necessary for O-
GlcNAcylation of Milton
Milton, unlike most other highly O-GlcNAcylated proteins, forms
a stable immunoprecipitable complex with OGT both in vitro and
in vivo (Brickley et al., 2011; Iyer et al., 2003; Iyer and Hart, 2003).
To determine whether we could selectively prevent Milton O-
GlcNAcylation by interferingwith this binding, wemapped the re-
gion required for its stable association with OGT. We expressed
truncated forms of both Drosophila MiltonA and hMilton1 in
HEK293T cells and assayed their ability to coprecipitate with58 Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc.OGT (Figures 4A and S4A–S4C). OGT binding appeared to
depend on residues between 450 and 750 of DrosophilaMiltonA
(Figure 4A) and 634–953 of hMilton1 (Figures S4A and S4B).
Although these are among the less conserved regions of Milton,
we identified a highly conserved 15 amino acid region (658–672
in hMilton1; Figure 4B). Deletion of these residues prevented
the coprecipitation of OGTwithMilton (Figure 4C). hMilton1 lack-
ing this OGT-binding domain (hMilton1DOBD) retained the ability
to coprecipitate with KHC and Miro and localize to mitochon-
dria (Figures S4C–S4E). However, although hMilton1DOBD no
longer bound OGT with sufficient affinity to coprecipitate, its O-
GlcNAcylation by OGT was not diminished but rather increased,
indicating that thehigh-affinity interaction interfereswith its ability
to modify Milton (Figures 4D and 4E). Thus, formation of a stable
OGT-Milton complex is not required for Milton to serve as a sub-
strate for OGT. The tetratricopeptide repeat (TPR) domains of
OGT, however, are thought to scaffold the interactions of OGT
with multiple substrates (Iyer and Hart, 2003; Lazarus et al.,
2011). Deletion of the first 6 TPR domains (D6 TPR) decreased
Milton O-GlcNAcylation, as anticipated (Figures 4F–4H), and
this truncated OGT did not arrest neuronal mitochondria (Figures
4I–4KandTableS1C). Thus, theGlcNAcylation ofMiltondoes not
require the exceptionally stable interaction of OGT with the OBD
domain onMilton but, as with other OGT substrates, requires the
substrate-recognizing TPR domains of OGT.
OGT-Dependent Mitochondrial Arrest Requires Milton
O-GlcNAcylation
We previously characterized four sites of O-GlcNAcylation on
Milton isolated from mouse synaptosomes (Trinidad et al.,
2012). To identify O-GlcNAcylation sites present in hMilton1,
this protein was immunoprecipitated from HEK293T cells and
resolved on an SDS-PAGE gel. Peptides isolated from a tryptic
digestion were analyzed by tandem mass spectrometry (MS/
MS) using electron transfer dissociation, which preserves labile
glycosidic linkages. We identified eight peptides on hMilton1
that were modified with O-GlcNAc. In three of these, the modi-
fied site could be localized to a single residue (Figure S5).
To determine the potential role of these sites in mitochondrial
arrest, we expressed in HEK293T cells hMilton1 constructs
wherein putative O-GlcNAcylation sites were mutated to alanine
(Figure S5 and Table S1D) andmeasured their relativeO-GlcNAc
levels. We focused on four O-GlcNAcylated serines conserved
between mouse and human Milton1 (Figure 5A). Mutation of
any of the four sites reduced the amount of GlcNAc immunoreac-
tivity present on Milton (Figure 5B). The requirement for Milton
O-GlcNAcylation in mediating the OGT-dependent mito-
chondrial arrest was demonstrated with a quadruple mutant
that had all four of these conserved serines changed to
alanine (hMilton1Qmut). We compared the consequences of its
expression to that of hMilton1 wild-type (WT) when OGT was
coexpressed. Therefore, we used hMilton1DNAat a lowconcen-
tration (0.2 mg/well of a 24-well plate) to minimize the increase in
motility caused by high levels ofMilton (Glater et al., 2006). By im-
munostaining, 96% ± 2.27% of neurons that were Mito-DsRed
positive were also myc-hMilton1 and OGT positive (Figure S5I).
The quadruple mutation, expressed on its own, increased mito-
chondrial length by 20% but had little effect on the parameters
AC
E
H I
F G
B
D
Figure 3. OGT and OGA Regulate hMilton1 O-GlcNAcylation
(A–D) Milton expression recruits OGT to axonal mitochondria. Hippocampal axons were cotransfected with eGFP-OGT, Mito-DsRed, and either an empty vector
(A and C) or myc-hMilton1 (B and D), and immunofluorescent intensity for eGFP-OGT and Mito-DsRed was measured along the length of the axons shown.
(E) Immunoprecipitation (IP) of endogenous hMilton1 from HEK293T cells to analyze the consequences of OGT overexpression. Precipitation with rabbit IgG was
used as a control. Input lanes were loaded with 3% of the cell lysates used for the IP and also probed with anti-GAPDH antibody as a loading control. OGT
overexpression increased its coprecipitation with Milton without decreasing the presence of Miro or KHC in the complex. A lower OGT-immunoreactive band in
the input lanes arises from the intramitochondrial isoform of OGT, which is not coprecipitated with hMilton1.
(F–I) Regulation of hMilton1 O-GlcNAcylation in HEK293T cells. Cells were transfected and treated as indicated. (F) myc-hMilton1 was immunoprecipitated with
anti-myc from cells treated overnight with 100 mMPUGNAC and/or overexpressing OGT. With fluorescently tagged secondary antibodies, band intensities were
quantified (G) in the linear range, and the intensity of eachGlcNAc bandwas normalized to the intensity ofmyc bands. GlcNAc levels onmyc-hMilton1 in untreated
cells were set as 1, and fold changes in response to PUGNAC treatment and OGT overexpression were calculated. n = 4 independent transfections per condition.
(H and I) myc-hMilton1 was immunoprecipitated fromHEK293T cells with or without overexpression of OGT or catalytically dead OGTH498N and its GlcNAcylation
quantified as in (G). n = 3 independent transfections per condition.
n.s., not significant. *p < 0.05 and **p < 0.01; one-way ANOVA. All values are shown as mean ± SEM. Scale bar, 10 mm. See also Figure S3.of mitochondrial movement when compared to WT Milton
expression (Table S1E) and therefore allowed a straightforward
comparison of the effect of OGT expression on mitochon-dria bearing either form of Milton. Three concentrations of
OGT DNA were used for transfections so as to construct a
dose/response relationship. As expected, mitochondrial motilityCell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc. 59
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Figure 4. An OGT/Milton Complex Is Not Required for hMilton1 O-GlcNAcylation
(A) Coimmunoprecipitation of full-length or truncated fly MiltonA and OGT proteins from HEK293T cells. Anti-DrosophilaMilton antibodies 5A124 (raised against
amino acids 908–1055) or 2A108 (raised against amino acids 273–450) were used to immunoprecipitate full-length (1–1,116) or truncated (750–1,116, 1–750, and
1–450) DrosophilaMiltonA. Immunoblots were probed with anti-OGT and the appropriate anti-Milton antibodies to identify Milton fragments that could associate
with OGT.
(B) Schematic representation of hMilton1 protein and sequence alignment of fly MiltonA (450–750) and hMilton1 (634–953) (see also Figure S4), which were
determined to be important for OGT/Milton complex formation. The conserved OBD is boxed; conserved amino acids are magenta. Predicted coiled-coil
domains of hMilton1 (CC1,2) are also illustrated.
(C) Myc-hMilton1 constructs lacking the indicated amino acids were tested for their ability to precipitate coexpressed OGT from HEK293T cells.
(legend continued on next page)
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decreased in both control and hMilton1 WT-expressing neurons
aswe increased theamount of transfectedOGTDNA (Figures 5D,
5E, and 5HandTable S1E). However, when hMilton1Qmut was ex-
pressed, OGT expression had no effect on their motility, even
when the highest concentration of OGT DNA was transfected
(Figures 5F–5H, Table S1E, and Movie S7). hMilton1Qmut pre-
vented the arrest whether or not the endogenous murine Milton
was knocked down by shRNA (Figures S5J and S5K). We also
analyzed mitochondrial motility in neurons expressing hMilton1
S447A, S829/30A, or S938A together with OGT overexpression
or PUGNAC treatment (Figure S5L). The individual mutations
were also effective in rendering motility resistant to OGT. Under-
standing the significance of individual sites will require further
elucidation of this mechanism.
Glucose-Dependent Changes in Mitochondrial Motility
Require Milton O-GlcNAcylation
Identification of the required O-GlcNAcylation sites on hMilton1
allowed us to use the protocol in Figure 1A to determine whether
this modification mediated the effect of increased extracellular
glucose. High glucose decreased movement in hippocampal
neurons expressing WT hMilton1 (Figures 6A, 6B, and 6E and
Table S1F). In contrast, motility increased in neurons expressing
hMilton1Qmut (Figures 6C–6E and Table S1F), particularly in the
anterograde direction. Thus, the suppression of mitochondrial
movement is mediated by the GlcNAcylation of Milton. In its
absence, mitochondria behave akin to the Syp vesicles of Fig-
ure 1, whose motility was enhanced when more glucose was
available. To determine the O-GlcNAcylation state of Milton
under different extracellular glucose conditions, we expressed
myc-tagged WT or Qmut hMilton1 constructs in HEK293T cells.
High glucose only increased the O-GlcNAcylation level of WT
hMilton1 (Figures 6F and 6G).
Loss of OGT Decreases the Stationary Mitochondrial
Pool In Vivo
Because the interaction of OGT with Milton is conserved (Fig-
ure 4A) (Glater et al., 2006), we took advantage of available
Drosophila lines to ask whether OGT was regulating mitochon-
drial movement in vivo. A piggyBac insertion into the ogt cod-
ing sequence (ogt/) (Schuldiner et al., 2008; ID:LL01151)
abolished detectable OGT protein (Figure S6A). Individual
axons in segmental nerves (Schuldiner et al., 2008; Wang
and Schwarz, 2009a) of ogt/ larvae had fewer stationary
mitochondria (Figures 7A–7C) and fewer mitochondria per
micron of axon than control larvae (Figure S6B). These results
in vivo in Drosophila parallel the effects of OGT knockdown(D and E) Full-length and D658-672 (DOBD) hMilton1 were immunoprecipitate
quantified as in Figure 3. Loss of the high-affinity interaction increased Milton O-
(F–H) Full-length and truncated OGT constructs lacking either the first 2.5 or 6 TR
length hMilton1 (WT) to evaluate the significance of the TPR motifs on OGT/Milto
was immunoprecipitated, and immunoblots were analyzed with anti-GlcNAc, an
(I–K) Hippocampal neurons were transfected with Mito-DsRed and either full-len
kymographs as in (I and J), mitochondrial motility was quantified (K) and compared
transfections per condition. n.s., not significant. *p < 0.05 and **p < 0.01; one-wa
10 mm and 100 s.
See also Figure S3 and Table S1C.in cultured hippocampal neurons and indicate a con-
served role of O-GlcNAc cycling in regulating mitochondrial
motility.
Milton O-GlcNAcylation Levels in Mouse Brain Are
Altered by Feeding
In tissue culture, changes in extracellular glucose altered the
extent ofMiltonGlcNAcylation (Figures 6F and 6G). To determine
whether it also varied in vivo, we took advantage of the fact that
the concentration of extracellular glucose in the brain changes in
parallel with blood glucose during fasting and feeding cycles
(Silver and Erecinska, 1994). Mice were either (1) fed ad libitum,
(2) fasted for 24 hr, or (3) fasted for 24 hr and then returned
to food for 24 hr (Figure 7D), after which their blood glucose
was monitored and cerebral cortices were removed to measure
Milton O-GlcNAcylation (Figures 7E and 7F). Although the drop
in blood glucose that accompanied fasting did not produce a
parallel decrease in Milton GlcNAcylation, refeeding following
the fasting significantly increased it.
Axonal Mitochondria Accumulate in Areas of Higher
Glucose
One possible consequence of the OGT pathway is that moving
mitochondria would tend to stop where cytosolic glucose
is elevated. To determine whether spatial inhomogeneities of
glucose could alter mitochondrial distribution in an axon, we
used microfluidic chambers to create a boundary between a
zone with 5mM glucose and one with glucose-free medium (Fig-
ures 7G and S6C). Because the glucose transporter will effec-
tively clamp the local cytoplasmic concentration at equilibrium
with the external glucose, a local difference in cytoplasmic
glucose should also arise. Hippocampal neurons were cultured
in chambers in 5 mM glucose and were allowed to grow their
axons through 0.45 mm grooves into an axonal chamber (Fig-
ure 7G). Trypan blue was used to confirm that fluidic isolation
of the axonal compartment was preserved during medium
exchanges (Figure S6C). To create the glucose differential, the
somal compartment was switched to glucose-free medium,
whereas the axonal compartment remained in 5 mM glucose.
A stretch of axon on the 5 mM glucose side of the glucose
discontinuity was imaged before and after the solution change
(Figure 7G). Lowering glucose in the somal compartment caused
an accumulation of mitochondria in this adjacent area of
higher glucose (Figures 7I and 7J). This accumulation is consis-
tent with a model in which the mobile mitochondria from
the glucose-free compartment arrest when they encounter the
region with higher glucose.d from 100 mM PUGNAC-treated HEK293T cells, and O-GlcNAcylation was
GlcNAcylation. nR 3 independent transfections per condition.
P motifs (D2.5, D6 as shown in F) were coexpressed in HEK293T cells with full-
n complex formation and the level of hMilton1 O-GlcNAcylation. myc-hMilton1
ti-myc, and anti-OGT. n = 3 independent transfections per condition.
gth or D2.5 or D6 truncated OGT and imaged 3 days after transfection. From
with control. n = 111–209mitochondria from 10 to 12 axons and 3 independent
y ANOVA, Kruskal-Wallis test. All values are shown as mean ± SEM. Scale bar,
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Figure 5. OGT-Dependent Mitochondrial Motility Arrest Requires Milton O-GlcNAcylation
(A) Sequence alignment of O-GlcNAcylation sites (magenta) in mouse Milton1 with homologous regions in hMilton1 (see also Figure S5 and Table S1D).
(B and C) Myc-hMilton1 with either individual putative GlcNAc sites mutated or the quadruple mutant lacking all four sites (Qmut) or WT were expressed in
HEK293T cells and cultured overnight with 100 mMPUGNAC.Milton immunoprecipitates were probed with anti-GlcNAc, anti-myc, and anti-OGT antibodies, and
GlcNAcylation levels on Milton were quantified with fluorescently tagged secondary antibodies. The intensity of each GlcNAc band was normalized to the in-
tensity of the myc band, with the baseline hMilton1 GlcNAc level set as 1 to reveal relative changes. nR 3 independent transfections per condition.
(D–G) Hippocampal neurons were transfected with Mito-DsRed and the indicated forms of hMilton1 with (E and G) or without (D and F) OGT (0.5 mg OGT DNA/
well). Mitochondrial motility was imaged 3 days after transfection. (H) To assess the effect of the mutated GlcNAcylation sites, a dose/response relationship was
established with different levels of DNA for OGT transfection and its effect onmitochondrial motility quantified from kymographs as in (D)–(G). The amount of OGT
DNA transfected per well of a 24-well plate is indicated. n = 75–174 mitochondria from 8 to 9 axons and 3 independent transfections per condition. All values are
shown as mean ± SEM. The significance of changes in motility was determined relative to the motility in neurons expressing the same Milton construct without
OGT transfection. n.s., not significant. *p < 0.05, **p < 0.01, and ***p < 0.001; one-way ANOVA, Kruskal-Wallis test. Scale bar, 10 mmand 100 s. See also Figure S5,
Movie S7, and Table S1E.DISCUSSION
Mitochondrial movement controls their distribution in cells, their
likelihood of fusing, and their rate of turnover in the cell periphery.
The control of mitochondrial movement can therefore influence
energy, signaling, metabolism, and Ca2+ buffering in different re-
gions of a cell (Saxton and Hollenbeck, 2012). We have now es-
tablished (1) that extracellular glucose regulates mitochondrial62 Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc.dynamics; (2) that the enzymeOGT, a putative metabolic sensor,
mediates this effect; (3) that a posttranslational modification of
Milton is an absolutely required target of this enzyme, and (4)
that the pathway is likely to be physiologically relevant in vivo
for regulating mitochondrial dynamics and distribution.
The GlcNAcylation level of Milton correlated well with mito-
chondrial motility, whether the level was manipulated by overex-
pression or knockdown of OGT, or by pharmacological inhibition
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Figure 6. Milton O-GlcNAcylation Is Necessary for Glucose to Decrease Mitochondrial Movement
(A–D) Hippocampal neurons were transfected with Mito-DsRed and either WT or Qmut hMilton1 constructs as indicated and cultured as per the protocol
described in Figure 1A.
(E) Percent time eachmitochondrion spent in anterograde and retrogrademotion was calculated from kymographs as in (A)–(D). n = 105–135mitochondria from 9
axons and 3 independent transfections per condition. Scale bar, 10 mm and 100 s. See also Table S1F.
(F and G) WT or Qmut myc-hMilton1 were expressed in HEK293T cells cultured in 25 mM glucose containing DMEM. Glucose levels were then lowered to 5 mM
for 24 hr before challenging them with 30 mM or 5 mM glucose for 2 hr as in the motility experiments. Milton immunoprecipitates were probed with anti-GlcNAc,
anti-myc, and anti-OGT antibodies (F), and GlcNAcylation levels on Milton were quantified (G). n = 4 independent transfections per condition.
All values are shown as mean ± SEM; n.s., not significant. *p < 0.05, **p < 0.01, and ***p < 0.001; Mann-Whitney U test, one-way ANOVA.of OGA or UDP-GlcNAc synthesis (Figure 2). OGT hasmany sub-
strates, including several such as tubulin, kinesin, and dynein
with potential impact on mitochondrial dynamics (Ji et al.,
2011; Ruan et al., 2012; Trinidad et al., 2012). However, by map-
ping and mutating four key sites of GlcNAc addition in hMilton1
(hMilton1Qmut), we demonstrated that Milton is the key and
essential substrate through which OGT inhibits mitochondrial
motility. These mutations had little effect on the baseline proper-
ties of mitochondrial movement but selectively prevented the
arrest by OGT (Figure 5). With hMilton1Qmut expression, we
also found that GlcNAcylation of Milton mediated the decrease
in mitochondrial movement caused by elevated extracellularglucose (Figure 6). Moreover, although, in this study, we took
advantage of the polarized arrays of microtubules in axons, the
components of this pathway are present in all metazoan cells
and glucose, via OGT, may therefore be a widespread regulator
of mitochondrial movement.
Protein GlcNAcylation is a posttranslational modification that
occurs on more than 1,000 proteins and has received much
recent attention (Ruan et al., 2013). OGT has low-affinity interac-
tions with many of its substrates but forms a stable complex with
few. Milton was one of the first identified high-affinity OGT part-
ners (Iyer et al., 2003; Iyer andHart, 2003), andwe have identified
a 15 amino acid region in hMilton1 (aa 658–672) that is requiredCell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc. 63
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Figure 7. Evidence of OGT-Dependent Regulation of Milton O-GlcNAcylation In Vivo
(A and B) In control and ogt/ larvae, UAS-mito-GFP was expressed in an identified peptidergic axon within the segmental nerve by CCAP-GAL4.
(C) The percent time eachmitochondrion spent in anterograde and retrogrademotion was calculated from kymographs as in (A) and (B). n = 91–100mitochondria
from 9 axons from 9 animals. Scale bar, 10 mm and 100 s.
(D) Schematic of the experimental regimen for changing blood glucose levels by fasting and refeeding andmeasured blood glucose levels from themice that were
used to compare Milton O-GlcNAcylation levels in the brain.
(E and F) Immediately after blood glucose measurements, two cortical hemispheres were removed and homogenized. Milton1 was immunoprecipitated (E), and
GlcNAcylation levels on Milton were quantified (F). n = 6 pairs of animals.
(legend continued on next page)
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for stable OGT-Milton complexes (Figures 5 and S4). However,
deletion of this region does not reduce hMilton1 O-GlcNAcyla-
tion (Figure 5D) on the critical sites. A similar dissociation of
OGT binding and O-GlcNAcylation has been described for
HCF-1 (Capotosti et al., 2011). OGT-Milton complexesmay facil-
itate OGT transport throughout cells or target OGT to the mito-
chondrial surface (Figure S3) for additional metabolic regulation.
O-GlcNAcylation, like phosphorylation, modifies serine and
threonine side chains; crosstalk and competition between phos-
phorylation and O-GlcNAcylation may be important for some
substrates (Hart et al., 2011). Twenty-eight hMilton1 phosphory-
lation sites have been previously identified (Hornbeck et al.,
2012), and we have mapped additional sites; however, no phos-
phorylation has been found at the critical O-GlcNacylation sites
that regulate mitochondrial motility.
SomeGlcNAcylation sites turn over very slowly andmay serve
a primarily structural role, whereas others are actively cycled and
likely regulate protein function (Khidekel et al., 2007). Only for the
latter class will PUGNAC inhibition of OGA cause the level of O-
GlcNAcylation to rise (Khidekel et al., 2007; Matthews et al.,
2007; Yi et al., 2012). Milton modification meets this criterion
(Figures 3F and 3G), and OGA inhibition decreased mitochon-
drial motility (Figure 2C). Thus, the GlcNAc sites on Milton are
undergoing dynamic regulation and normally exist in a substoi-
chiometric level of modification that allows the motor/adaptor
complex to respond to changes in glucose availability.
The inhibitory effect of increased extracellular glucose on
mitochondrial movement was not shared by Syp-vesicles in
the same axons, although both organelles use dynein for retro-
grade movement. Indeed, the movement of Syp vesicles was
increased when glucose was raised (Figure 1). Mechanistically,
this distinction is explained by two factors. (1) The locus of the
inhibitory regulation is not in themotors themselves but inMilton,
which is specific to mitochondria. (2) Changing extracellular
glucose from 5.5 to 30 mM has been calculated to increase
ATP 3-fold in hippocampal neurons (Huang et al., 2007), and
raising ATP levels enhances the activity of kinesin and dynein,
which require ATP hydrolysis for force generation (Fort et al.,
2011; Visscher et al., 1999). Therefore, in the absence of the
overriding influence of Milton GlcNAcylation, cargo transport
will increase with increased glucose availability, a phenomenon
we also observed for mitochondria when the action of OGT
was prevented by expression of hMilton1Qmut (Figure 6). Local
microdomains of ATP can affect the velocity and extent of
vesicle motility. Organelles can increase the efficiency of their
transport by carrying their own ATP-generating machinery and
mitochondrial motors require ATP produced by mitochondria
(Zala et al., 2013).(G) Schematic of the microfluidic-based culture platform. The culture chamber c
microgrooves. Glucose levels in the axonal and somal compartments were indepe
at the proximal end of the axonal compartment.
(H–J) Hippocampal neurons, cultured inmicrofludic devices in 5mMglucose (with
the somal compartment was replaced with either the same solution or with a g
imaged both before and 1 hr after this solution change (H) so that its effect on
4 microfluidic devices per condition, 3 independent experiments.
All values are shown as mean ± SEM; n.s., not significant. *p < 0.05 and ****p <
Figure S6.The OGT pathway can now be added to a growing list of
signaling cascades that regulate themotile pool of mitochondria,
including changes in cytosolic Ca2+ (Macaskill et al., 2009; Wang
and Schwarz, 2009b), growth factors and their downstream ki-
nases (Chada and Hollenbeck, 2003), hypoxia (Li et al., 2009),
Armcx (Lo´pez-Dome´nech et al., 2012), and the PINK1/Parkin
pathway (Wang et al., 2011). It is noteworthy, however, that
although each of these pathways can increase the number of
stationary mitochondria, they do not account for the majority of
stationary mitochondria in an axon. In Drosophila lacking OGT,
60% of the mitochondria remained stationary (Figures 7A–7C).
Similarly, 60% of axonal mitochondria remained stationary
upon knockdown of OGT or block of UDP-GlcNAc synthesis
(Figure 2), and a similar fraction is stationary upon expression
of Ca2+-resistant Miro or mutation of PINK1 or Parkin (Wang
and Schwarz, 2009b; Wang et al., 2011). This persistently sta-
tionary mitochondrial pool is dependent on anchoring proteins,
including Syntaphilin (Kang et al., 2008) and Myosin VI (Pathak
et al., 2010). This distinction between anchored mitochondria
unchanged by short-term signals and a mobile pool that can
be arrested when necessary may help the cell balance an
adequate baseline of mitochondria throughout the cell while
fine-tuning their distribution via the mobile pool as nutrient
supply and energetic demand fluctuate.
In this study, we determined that the OGT/O-GlcNAcylation
pathway enables neuronal mitochondrial motility to respond
to changes in glucose availability. Although most measurements
were conducted in cultured cells where glucose availability can
readily be altered, our data indicate that the pathway also func-
tions in vivo. In Drosophila, removal of OGT increased the frac-
tion of mobile mitochondria, demonstrating that there is a tonic
inhibition by the OGT pathway (Figures 7A–7C). In addition, we
demonstrated that the extent of GlcNAcylation of Milton in
mouse brain in vivo could vary—the increase in glucose availabil-
ity upon feeding previously fasted mice increased the level of
Milton O-GlcNAcylation (Figures 7D–7F). In principle, the
pathway in vivo could respond to either spatial differences or
temporal changes in glucose concentration and has the potential
to enrichmitochondria in subcellular locations of high glucose for
efficient ATP production. Indeed, when we created a differential
in glucose concentration in microfluidic chambers, mitochon-
drial density increased where glucose was high. Little is known
about cytoplasmic glucose concentrations in neurons, but the
inhomogeneous distribution of glucose transporters (Gerhart
et al., 1992) and OGT and OGA (Akimoto et al., 2003; Cole and
Hart, 2001; Tallent et al., 2009) in vivo suggests that both the
glucose supply and key enzymes may be heterogeneously
distributed. In addition, some parts of neurons likely have betteronsists of fluidically isolated somal and axonal compartments connected by
ndently manipulated, andmitochondria were imaged in a 50 mm length of axon
1mM lactate and pyruvate), were transfected withMito-DsRed. Themedium in
lucose-free medium (with 1 mM lactate and pyruvate). The same axons were
mitochondrial density and mass could be quantified (I and J). n = 21 axons,
0.0001; Mann-Whitney U test, one-way ANOVA, Kruskal-Wallis test. See also
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access to extracellular glucose, such as nodes of Ranvier
or areas close to blood vessels. Altered distribution of mitochon-
dria is only one likely consequence; because mitochondrial
fusion is highly dependent on their motility, increased Milton
GlcNAcylation is likely to decrease fusion and the exchange of
components and have consequences for metabolism (Liesa
and Shirihai, 2013; Liu and Hajno´czky, 2011). Temporal changes
in glucose availability are also relevant to neuronal metabolism.
In both the central and peripheral nervous system, fasting and
feeding alters levels of extracellular glucose (Choeiri et al.,
2002; Dash et al., 2013; Silver and Erecinska, 1994). Further-
more, during synaptic activity and action potential firing, sur-
face glucose transporter levels and hence glucose uptake is
increased, as is ATP consumption (Ferreira et al., 2011; Weisova´
et al., 2009). Thus, during intense synaptic activity, the local
activation of OGT and O-GlcNAcylation of Milton would cause
existing mitochondria to be retained at pre- and postsynaptic
sites and would capture any nearby transiting mitochondria.
The resulting enrichment for mitochondria would enhance ATP
production and Ca2+ buffering to preserve synaptic efficacy.
On the other hand, poorly regulated blood glucose gives rise to
diabetic neuropathy, and it is tempting to speculate that misre-
gulation of mitochondrial motility in peripheral axons, via the
pathway described here, could cause insufficient turnover of pe-
ripheral mitochondria and thereby contribute to axonal
degeneration.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
Standard PCR-based cloning strategies were used (see the Extended Exper-
imental Procedures).
Cell Culture and Transfection
HEK293T and COS7 cells were cultured in DMEM supplemented with L-
glutamine, penicillin/streptomycin (Life Technologies), and 10% FBS (Atlanta
Premium). Plasmid DNA transfections were performed with the calcium
phosphate method. When used, PUGNAC (Tocris Bioscience) was applied
at 100 mM for 12–20 hr before cell lysis.
Hippocampal neuronswere isolated from E18 rat (Charles River) embryos as
previously described (Nie and Sahin, 2012) and plated at 5–7 3 104/cm2 den-
sity on coverslips (Bellco Glass) coated with 20 mg/ml poly-L-ornithine (Sigma)
and 3.5 mg/ml laminin (Life Technologies) and maintained in NB medium sup-
plemented with B27 (Life Technologies), L-glutamine, and penicillin/strepto-
mycin, unless modified as specified. Seven to ten DIV hippocampal neurons
were transfected using Lipofectamine2000 (Life Technologies) and imaged
2–3 days later. The coexpression of multiple constructs transfected into
neurons was validated by retrospective immunostaining following live-cell
imaging. For particular treatments of neuronal cultures, see the Extended
Experimental Procedures.
Live-Cell Imaging and Motility Analysis
For live-cell imaging of axonal mitochondria and Syp-vesicles, coverslips were
transferred to HibernateE (BrainBits) medium to maintain cell viability in CO2-
free conditions. Kymographs were generated from 3- to 5-min-long time-lapse
movies and analyzed with Kymolyzer, a custom-written ImageJmacro (see the
Extended Experimental Procedures for details) for percent time in motion,
velocity, total distance traveled, mitochondrial density, and length.
Immunocytochemistry and Protein Analyses
Hippocampal neurons and COS7 cells were fixed and immunostained as pre-
viously (Glater et al., 2006; Stowers et al., 2002) with the indicated antibodies66 Cell 158, 54–68, July 3, 2014 ª2014 Elsevier Inc.(see the Extended Experimental Procedures). Images were processed with
ImageJ (Schneider et al., 2012) using only linear adjustments of contrast and
color. HEK293T cells lysis and immunoprecipitations were performed as
previously with minor modifications (Glater et al., 2006). For immunodetection
and hMilton1 GlcNAcylation measurements from immunoprecipitates, see the
Extended Experimental Procedures.
Drosophila Stocks and Mitochondrial Motility Analysis
The following Drosophila stocks were used: CCAP-GAL4 (Park et al., 2003),
UAS-mito-GFP (Pilling et al., 2006), and ogt/ (Schuldiner et al., 2008).
Dissected third-instar larvae were imaged in a chamber on a glass slide.
Kymographs were generated and analyzed as described previously (Wang
and Schwarz, 2009a).
Statistical Analysis
Throughout the paper, data are expressed asmean ± SEM. Statistical analysis
was performed with GraphPad Prism v6.0 for MacOSX. The Mann-Whitney U
test was used to determine the significance of differences between two con-
ditions. Multiple conditions were compared by Kruskal-Wallis nonparametric
ANOVA test, which was followed by Dunn’s multiple comparisons test or by
one-way ANOVA with post hoc Tukey’s test as appropriate to determine sig-
nificance of differences across every condition to control condition. p < 0.05
was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, one table, and seven movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2014.06.007.
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